牛叉诊股

[{"date":"2026.09.29","stock":"0.42","trade":"0.13","ind":"0.34"},{"date":"2026.09.28","stock":"0.28","trade":"-0.49","ind":"-3.44"},{"date":"2026.09.24","stock":"0.43","trade":"-2.45","ind":"-2.34"},{"date":"2026.09.23","stock":"-0.28","trade":"-0.73","ind":"-0.64"},{"date":"2026.09.22","stock":"1.44","trade":"0.53","ind":"-0.05"},{"date":"2026.09.21","stock":"3.28","trade":"4.67","ind":"0.65"},{"date":"2026.09.18","stock":"-1.47","trade":"0.73","ind":"1.72"},{"date":"2026.09.17","stock":"1.19","trade":"1.11","ind":"-0.33"},{"date":"2026.09.16","stock":"0.75","trade":"0.58","ind":"1.26"},{"date":"2026.09.15","stock":"-2.05","trade":"-1.55","ind":"-0.72"},{"date":"2026.09.14","stock":"1.19","trade":"1.85","ind":"-0.64"},{"date":"2026.09.11","stock":"-2.46","trade":"-2.37","ind":"-1.08"},{"date":"2026.09.10","stock":"-0.43","trade":"-1.85","ind":"-0.77"},{"date":"2026.09.09","stock":"-0.14","trade":"-1.49","ind":"0.15"},{"date":"2026.09.08","stock":"1.02","trade":"1.50","ind":"-0.52"},{"date":"2026.09.07","stock":"0.73","trade":"0.38","ind":"1.91"},{"date":"2026.09.04","stock":"-0.87","trade":"-0.60","ind":"-0.79"},{"date":"2026.09.03","stock":"-0.43","trade":"-0.47","ind":"0.10"},{"date":"2026.09.02","stock":"-1.56","trade":"-1.10","ind":"-1.88"},{"date":"2026.09.01","stock":"2.03","trade":"1.18","ind":"-1.02"},{"date":"2026.08.31","stock":"-0.86","trade":"-1.47","ind":"0.44"}]

同和药业,深证成指,化学制药指数

压力支撑

该股压力位为7.09元，支撑位为7.02元。

[{"text":"\u538b\u529b\u4f4d","value":"7.09","date":1790611200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.02","date":1790611200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.6资金面打败了75%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：09月29日 20:30

机构今日流向(万元)	-137.05	机构5日流向(万元)	-6750.90
机构10日流向(万元)	-5323.66	机构20日流向(万元)	-14350.29

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量增加585.17万股，其中基金净减仓5家，主力净减仓7家，暂未发现中长期投资价值。

截止2026-06-30，共53家主力机构（基金49家，一般法人3家，社保基金1家），持仓量总计7890.68万股，占流通A股21.48%
其中，基金持仓与2025-12-31相比：
增仓：5家，增持 393.66万股
减仓：10家，减持 138.65万股
新出现在主力名单中：30家，持有576.74万股
从主力名单中消失：37家，原持有246.58万股

消息面诊股

诊断结果：5.5消息面打败了34%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-09-16
一般消息	募资投向	公司购买资产	2026-09-16
一般消息	重大事项	关联交易	2026-09-16
一般消息	重大事项	公司股东股份解押	2026-09-07
一般消息	分红转增	不分配不转增	2026-08-26
一般消息	股东大会	年度股东大会	2026-04-29
利好	分红转增	10派0.4元(含税)	2026-04-29
一般消息	高管变动	取消监事会	2025-11-11

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：3.8行业面打败了48%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2026.09.29","price":"0.34","value":"0.13"},{"date":"2026.09.28","price":"-3.44","value":"-0.49"},{"date":"2026.09.24","price":"-2.34","value":"-2.45"},{"date":"2026.09.23","price":"-0.64","value":"-0.73"},{"date":"2026.09.22","price":"-0.05","value":"0.53"},{"date":"2026.09.21","price":"0.65","value":"4.67"},{"date":"2026.09.18","price":"1.72","value":"0.73"},{"date":"2026.09.17","price":"-0.33","value":"1.11"},{"date":"2026.09.16","price":"1.26","value":"0.58"},{"date":"2026.09.15","price":"-0.72","value":"-1.55"},{"date":"2026.09.14","price":"-0.64","value":"1.85"},{"date":"2026.09.11","price":"-1.08","value":"-2.37"},{"date":"2026.09.10","price":"-0.77","value":"-1.85"},{"date":"2026.09.09","price":"0.15","value":"-1.49"},{"date":"2026.09.08","price":"-0.52","value":"1.50"},{"date":"2026.09.07","price":"1.91","value":"0.38"},{"date":"2026.09.04","price":"-0.79","value":"-0.60"},{"date":"2026.09.03","price":"0.10","value":"-0.47"},{"date":"2026.09.02","price":"-1.88","value":"-1.10"},{"date":"2026.09.01","price":"-1.02","value":"1.18"},{"date":"2026.08.31","price":"0.44","value":"-1.47"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	津药药业	29.70%	9.70%	6.2分
2	纳微科技	23.99%	-3.56%	6.4分
3	普洛药业	22.51%	7.01%	6.6分
4	丽珠集团	22.04%	20.71%	6.5分
5	华纳药厂	21.31%	-4.81%	6.0分
6	国邦医药	18.97%	-1.00%	6.3分
7	亚虹医药	15.94%	-6.65%	5.6分
8	东亚药业	14.54%	0.36%	5.0分
9	苑东生物	14.45%	0.76%	5.9分
10	首药控股	12.75%	-2.94%	5.5分
11	灵康药业	12.55%	1.86%	6.6分
12	金石亚药	11.92%	-0.56%	5.7分
13	多瑞医药	10.76%	-6.58%	5.1分
14	华仁药业	10.69%	-2.43%	5.6分
15	海森药业	10.28%	3.74%	5.8分
16	吉贝尔	9.66%	4.16%	6.2分
17	北陆药业	8.31%	8.94%	6.2分
18	奥赛康	8.26%	-1.04%	6.2分
19	-	8.19%	1.52%	分
20	赛分科技	7.98%	-8.72%	7.0分
21	-	7.79%	1.45%	分
22	宣泰医药	7.63%	-0.90%	6.2分
23	ST能特	7.59%	-9.89%	4.9分
24	健康元	7.49%	5.32%	6.2分
25	宏辉果蔬	6.68%	-8.16%	4.8分
26	海翔药业	6.38%	9.09%	5.5分
27	民生健康	6.30%	2.94%	6.5分
28	天新药业	5.90%	-0.63%	6.1分
29	ST诺泰	5.88%	0.65%	5.7分
30	汇宇制药	5.55%	-1.22%	5.9分
31	奥翔药业	5.30%	2.91%	5.5分
32	键凯科技	5.26%	5.15%	6.0分
33	新华制药	5.03%	-4.70%	5.4分
34	复星医药	4.61%	1.48%	5.8分
35	小方制药	4.55%	-3.71%	5.0分
36	汉商集团	4.46%	0.25%	6.3分
37	花园生物	4.00%	-8.80%	5.2分
38	富士莱	3.79%	4.88%	6.2分
39	威尔药业	3.62%	-0.48%	6.0分
40	-	3.57%	-13.41%	分
41	共同药业	3.39%	-3.32%	5.9分
42	拓新药业	3.33%	1.43%	5.4分
43	天宇股份	2.95%	3.87%	6.5分
44	同和药业	2.90%	2.31%	5.7分
45	ST复华	2.90%	-3.35%	4.6分
46	莎普爱思	2.72%	1.17%	6.2分
47	ST天圣	2.68%	1.16%	4.4分
48	亨迪药业	2.56%	-1.43%	6.0分
49	凯因科技	2.56%	1.04%	5.8分
50	富祥股份	2.50%	-15.46%	5.2分
51	山河药辅	2.42%	-1.13%	5.1分
52	科源制药	2.01%	-7.30%	5.1分
53	哈三联	1.96%	-0.46%	5.7分
54	仟源医药	1.91%	0.55%	5.9分
55	复旦张江	1.73%	0.49%	5.9分
56	易明医药	1.32%	1.20%	5.8分
57	ST人福	1.18%	0.27%	5.7分
58	新天地	1.08%	-0.96%	5.7分
59	华北制药	1.04%	-4.72%	4.9分
60	-	0.47%	-11.70%	分
61	溢多利	0.35%	-0.52%	4.8分
62	广济药业	0.00%	-2.22%	5.6分
63	金城医药	-0.15%	-4.35%	5.4分
64	华东医药	-0.22%	0.34%	6.2分
65	石药创新	-0.27%	-4.98%	6.2分
66	-	-0.27%	-2.86%	分
67	仙琚制药	-0.46%	-0.92%	5.5分
68	健友股份	-0.63%	0.00%	6.2分
69	翰宇药业	-0.74%	-3.39%	5.3分
70	华海药业	-0.74%	-4.02%	5.7分
71	罗欣药业	-0.83%	-2.64%	5.8分
72	东诚药业	-0.86%	-0.08%	6.0分
73	恒瑞医药	-0.98%	-0.91%	6.4分
74	华润双鹤	-1.00%	-1.24%	5.4分
75	本立科技	-1.04%	1.47%	5.2分
76	上海谊众	-1.20%	-6.77%	5.4分
77	盟科药业	-1.21%	-3.54%	5.8分
78	海辰药业	-1.29%	-3.34%	5.4分
79	辰欣药业	-1.46%	-1.66%	5.5分
80	鲁抗医药	-1.68%	-2.93%	5.3分
81	福元医药	-1.72%	-2.14%	5.9分
82	美诺华	-1.74%	-6.85%	5.0分
83	泰恩康	-1.75%	-9.19%	5.2分
84	力生制药	-1.84%	-1.42%	5.2分
85	微芯生物	-1.97%	-4.99%	5.7分
86	-	-2.06%	-3.70%	分
87	卫信康	-2.18%	-0.77%	6.4分
88	海创药业	-2.33%	-1.94%	5.9分
89	恩华药业	-2.41%	-1.60%	5.6分
90	尔康制药	-2.42%	-3.29%	4.9分
91	福安药业	-2.53%	-3.26%	5.0分
92	华邦健康	-2.96%	-4.05%	4.6分
93	国药现代	-2.96%	-1.91%	5.5分
94	贝达药业	-3.01%	-0.91%	6.0分
95	奥锐特	-3.02%	-4.46%	5.8分
96	德展健康	-3.03%	-4.76%	4.4分
97	悦康药业	-3.21%	-3.28%	5.4分
98	向日葵	-3.27%	-4.82%	3.8分
99	诚意药业	-3.34%	-1.00%	5.6分
100	科伦药业	-3.35%	-7.67%	5.5分
101	九典制药	-3.35%	-2.91%	5.0分
102	润都股份	-3.43%	-5.89%	5.4分
103	-	-3.46%	-3.54%	分
104	百济神州	-3.85%	-3.05%	5.6分
105	丰原药业	-3.95%	-3.49%	5.4分
106	北大医药	-4.06%	-1.81%	4.8分
107	艾力斯	-4.08%	4.07%	6.7分
108	千红制药	-4.09%	-4.09%	5.1分
109	迪哲医药	-4.22%	-7.57%	5.6分
110	海正药业	-4.27%	-3.71%	5.2分
111	海普瑞	-4.28%	-1.94%	5.7分
112	东北制药	-4.29%	-4.09%	5.2分
113	金陵药业	-4.32%	-4.46%	5.2分
114	中哲精化	-4.46%	-1.64%	5.7分
115	ST南新	-4.90%	-3.90%	4.5分
116	博瑞医药	-5.19%	-5.24%	4.7分
117	司太立	-5.52%	-2.56%	5.4分
118	立方制药	-5.57%	-4.02%	6.1分
119	亿帆医药	-5.62%	-4.15%	5.4分
120	浙江医药	-5.80%	-4.99%	4.9分
121	兴齐眼药	-5.98%	-3.07%	5.0分
122	亚太药业	-6.08%	-6.25%	4.6分
123	-	-6.08%	-4.60%	分
124	华特达因	-6.09%	-3.28%	5.1分
125	信立泰	-6.14%	-4.59%	5.6分
126	新和成	-6.25%	-5.34%	5.6分
127	-	-6.27%	-4.43%	分
128	常山药业	-6.47%	-8.22%	4.5分
129	双鹭药业	-6.52%	-5.57%	4.5分
130	海思科	-6.56%	-8.12%	6.3分
131	海南海药	-6.87%	-9.07%	4.6分
132	前沿生物	-6.92%	-5.25%	5.3分
133	川宁生物	-6.94%	-3.13%	4.9分
134	西点药业	-7.01%	-1.34%	5.6分
135	ST惠程	-7.03%	-2.46%	4.6分
136	海欣股份	-7.06%	-8.99%	4.7分
137	莱美药业	-7.18%	-3.81%	5.4分
138	赛托生物	-7.61%	-1.24%	6.1分
139	石药景峰	-7.75%	-4.03%	4.8分
140	舒泰神	-7.89%	-5.51%	4.9分
141	联环药业	-8.07%	-3.71%	5.6分
142	通化金马	-8.39%	-4.05%	5.0分
143	益方生物	-8.40%	-7.94%	5.0分
144	中关村	-8.50%	-2.38%	5.4分
145	泽璟制药	-9.30%	-10.65%	5.4分
146	广生堂	-9.34%	-6.88%	4.1分
147	一品红	-9.72%	-6.40%	5.1分
148	宏源药业	-10.30%	-4.10%	5.1分
149	昂利康	-10.72%	-6.44%	4.6分
150	百利天恒	-11.56%	-10.92%	5.1分
151	京新药业	-11.61%	-3.49%	5.2分
152	必贝特	-12.67%	-8.64%	6.1分
153	永安药业	-14.53%	-11.38%	5.1分
154	康芝药业	-18.94%	-6.63%	4.5分
155	誉衡药业	-20.59%	-7.22%	5.1分
156	哈药股份	-21.71%	-13.45%	5.0分
157	圣诺生物	-24.77%	-27.52%	5.2分
158	冀衡医药	-27.05%	-5.53%	4.4分
159	神奇制药	-27.33%	-12.32%	5.1分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.1基本面打败了61%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（50分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 107/217 ， 118/217。

[{"date":"2026-06-30","value":"1.04","vol":"-0.11"},{"date":"2026-03-31","value":"0.79","vol":"0.46"},{"date":"2025-12-31","value":"3.13","vol":"-1.74"},{"date":"2025-09-30","value":"3.57","vol":"1.58"},{"date":"2025-06-30","value":"2.51","vol":"1.29"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	1.04	0.79	3.13	3.57	2.51
行业(%)	-0.11	0.46	-1.74	1.58	1.29

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"28.13","vol":"49.56"},{"date":"2026-03-31","value":"28.55","vol":"50.37"},{"date":"2025-12-31","value":"30.26","vol":"49.72"},{"date":"2025-09-30","value":"30.70","vol":"49.19"},{"date":"2025-06-30","value":"31.45","vol":"49.45"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	28.13	28.55	30.26	30.70	31.45
行业(%)	49.56	50.37	49.72	49.19	49.45

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 111/217 ， 133/217。

[{"date":"2026-06-30","value":"-10.35","vol":"20.25"},{"date":"2026-03-31","value":"-1.34","vol":"24.03"},{"date":"2025-12-31","value":"9.19","vol":"38.08"},{"date":"2025-09-30","value":"11.63","vol":"140.73"},{"date":"2025-06-30","value":"11.88","vol":"78.18"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	-10.35	-1.34	9.19	11.63	11.88
行业(%)	20.25	24.03	38.08	140.73	78.18

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"-57.99","vol":"366.18"},{"date":"2026-03-31","value":"-9.63","vol":"51.69"},{"date":"2025-12-31","value":"-31.42","vol":"-24.28"},{"date":"2025-09-30","value":"-12.61","vol":"3.38"},{"date":"2025-06-30","value":"-15.91","vol":"65.15"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	-57.99	-9.63	-31.42	-12.61	-15.91
行业(%)	366.18	51.69	-24.28	3.38	65.15

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 120/217 ， 130/217。

[{"date":"2026-06-30","value":"0.12","vol":"0.21"},{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.25","vol":"0.41"},{"date":"2025-09-30","value":"0.19","vol":"0.30"},{"date":"2025-06-30","value":"0.13","vol":"0.21"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.12	0.06	0.25	0.19	0.13
行业(次)	0.21	0.10	0.41	0.30	0.21

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.52","vol":"1.27"},{"date":"2026-03-31","value":"0.25","vol":"0.65"},{"date":"2025-12-31","value":"1.09","vol":"2.57"},{"date":"2025-09-30","value":"0.81","vol":"1.93"},{"date":"2025-06-30","value":"0.54","vol":"1.29"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	0.52	0.25	1.09	0.81	0.54
行业(次)	1.27	0.65	2.57	1.93	1.29

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 26/217 ， 107/217。

[{"date":"2026-06-30","value":"34.54","vol":"4.77"},{"date":"2026-03-31","value":"12.18","vol":"-2.17"},{"date":"2025-12-31","value":"4.62","vol":"16.33"},{"date":"2025-09-30","value":"31.30","vol":"4.90"},{"date":"2025-06-30","value":"38.31","vol":"2.94"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	34.54	12.18	4.62	31.30	38.31
行业	4.77	-2.17	16.33	4.90	2.94

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"1.39","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.21","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.73","vol":"1.72"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	1.39	-	2.21	-	2.73
行业	1.32	0.00	1.60	0.00	1.72

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/217 ， 52/217。

[{"date":"2026-06-30","value":"1.93","vol":"3.55"},{"date":"2026-03-31","value":"1.82","vol":"3.57"},{"date":"2025-12-31","value":"2.19","vol":"3.38"},{"date":"2025-09-30","value":"2.56","vol":"3.46"},{"date":"2025-06-30","value":"3.01","vol":"3.72"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	1.93	1.82	2.19	2.56	3.01
行业	3.55	3.57	3.38	3.46	3.72

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.55","vol":"2.85"},{"date":"2026-03-31","value":"0.52","vol":"2.93"},{"date":"2025-12-31","value":"0.62","vol":"2.75"},{"date":"2025-09-30","value":"0.63","vol":"2.72"},{"date":"2025-06-30","value":"1.16","vol":"2.93"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	0.55	0.52	0.62	0.63	1.16
行业	2.85	2.93	2.75	2.72	2.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 82/217 ， 88/217。

[{"date":"2026-06-30","value":"25.34","vol":"33.40"},{"date":"2026-03-31","value":"28.01","vol":"33.15"},{"date":"2025-12-31","value":"28.78","vol":"34.33"},{"date":"2025-09-30","value":"27.09","vol":"33.76"},{"date":"2025-06-30","value":"28.08","vol":"33.99"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	25.34	28.01	28.78	27.09	28.08
行业(%)	33.40	33.15	34.33	33.76	33.99

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.34","vol":"0.71"},{"date":"2026-03-31","value":"0.39","vol":"9.70"},{"date":"2025-12-31","value":"0.40","vol":"1.75"},{"date":"2025-09-30","value":"0.37","vol":"1.18"},{"date":"2025-06-30","value":"0.39","vol":"0.87"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.34	0.39	0.40	0.37	0.39
行业(%)	0.71	9.70	1.75	1.18	0.87

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中泰证券	2026-09-08	买入
华创证券	2026-09-04	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"1.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.06","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.80","blueLineValue":"0.19","type":"YC"}]

[同和药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]